News

Global Health Solutions Retains Objective Capital Partners As Exclusive Advisor for Acquiring Strategic Partnerships

San Diego, CA, May 15, 2017 Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, has announced that it has been retained as exclusive advisor to Global Health Solutions, LLC, to assist the company in exploring strategic partnerships and licensing agreements for its diverse product portfolio and pipeline for wound care, infection, and skin care. The priority focus will be on seeking best in class commercialization partners for the Company’s 510K FDA-cleared Hexagen™ Wound Dressing, which addresses the pressing need for effective solutions in the chronic and advanced wound market(s).  Additional assets to be partnered include the FiltreX™ Adhesive Dressing and pipeline assets in dermatology, infection control, biologics, and aesthetics. (more…)

Objective Capital Partners Announced as Finalist for Boutique Investment Banking Firm of the Year

San Diego, CA, May 9, 2017 Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, has been announced as a finalist for Boutique Investment Banking Firm of the Year as part of the 9th Annual International M&A Advisor Awards. The M&A Advisor also recognized Objective Capital Partners as finalists in categories for Consumer Discretionary Deal of the Year and Corporate Strategic Deal of the Year ($100mm-250mm).  This is the third year in a row that Objective Capital Partners has been nominated by The M&A Advisor as an award finalist. (more…)

A Roundtable for Life Science Executives: Private Capital Raising

Join CohnReznick, Objective Capital Partners, Wilson Sonsini and an Exclusive Group of Life Science Executives for Engaging Discussion on May 17

San Diego, CA- April 18, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that they have teamed up with CohnReznick and Wilson Sonsini Goodrich & Rosati  to sponsor a  Roundtable discussion on Private Capital Raising for Life Science Companies on Wednesday, May 17, 2017.  The Roundtable discussion will take place from 7:30-9:00 am at Barney & Barney in San Diego, CA.  (more…)

ACG San Diego Private Capital Expo: Healthcare

Objective Capital’s David H. Crean to Lead Discussion on Healthcare Topics at March 23rd Event 

San Diego, CA- March 10, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors and Head of its Life Sciences and Healthcare practice, will lead a group of expert panelists at San Diego’s Association of Corporate Growth (ACG) 7th Annual Private Capital Expo on March 23, 2017 from 5:00-8:00 PM. The panel will address Overall Valuation & Activity Levels in Private Capital Markets as part of a breakout session on Healthcare and Life sciences. Additional panel discussions will explore activity in three other dynamic business sectors including Software & Technology, Action Sports, and Industrial & Manufacturing. (more…)

Objective Capital Opens Los Angeles Office

San Diego, CA- March 7, 2017 – Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that the firm has opened a Los Angeles office as part of Objective Capital’s continued commitment to serve its Los Angeles and Orange County clients. This new office will broaden Objective Capital’s footprint in the Southern California region and further support Objective Capital’s team members serving its Los Angeles and Orange County clients as the firm continues to grow. Channing Hamlet, Managing Director of Objective Capital, will serve as principal lead at the Los Angeles office. (more…)

David H. Crean to Address Current Capital Raising Issues and Strategies for Biotech Companies to the Association of Corporate Counsel Life Sciences Roundtable

 

San Diego, CA- February 3, 2017 – Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors and Head of its Life Sciences and Healthcare practice, will be a guest panelist speaker at Association of Corporate Counsel (ACC) of San Diego on March 2, 2017 from 5:00-6:30 PM. Dr. Crean will be joined by fellow panelists Dennis Doucette, Partner, Corporate & Securities, Practice Group Leader for Procopio, and David Szekeres, Senior Vice President, Business Development, General Counsel and Corporate Secretary for Heron Therapeutics, Inc. The panel will address Current Capital Raising Issues and Strategies for Biotech Companies. The event will be held at the offices of Procopio, Cory, Hargreaves & Savitch LLP, 12544 High Bluff Drive, Suite 300, San Diego, CA 92130. (more…)

San Diego Venture Group (SDVG) Adds Trever Acers to Its Board of Directors

San Diego, CA- February 1, 2017 – Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that Trever Acers, one of its Managing Directors, has been elected to serve on the Board of Directors for San Diego Venture Group (SDVG).  SDVG is a non-profit organization designed to bring together entrepreneurs, advisors and capital providers who are interested in new ventures and furthering individual companies, as well as San Diego’s overall innovation community. (more…)

Objective Capital Partners Strengthens Its Healthcare & Life Sciences Investment Banking Practice with the Addition of Jack J. Florio

San Diego, CA- January 18, 2017 – Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to welcome the addition of Jack J. Florio fueling its ability to secure and execute high quality deals in the healthcare & life sciences space.  Mr. Florio brings more 40 years’ of global life sciences experience in major pharmaceutical, biotechnology, medical devices and digital health companies.  He has held senior management roles in both small and large companies including CEO, Corporate Development and Business Development.  He will serve as Managing Director and help with execution of the firm’s investment banking activities in the healthcare & life science space alongside David H. Crean, Ph.D.. (more…)

Objective Capital Partners Trever Acers to Address Company Needs for Obtaining Capital at the CFO Leadership Council

San Diego, CA- January 14, 2017 – Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that Trever Acers, one of its Managing Directors, will be a guest panelist speaker at the CFO Leadership Council on February 16, 2017 from 7:15-9:30 AM. Mr. Acers will be joined by fellow panelists Craig Dupper, Managing Partner at Solis Capital Partners, Michael Umansky, Partner at Sheppard Mullin Richter & Hampton LLP and Gordon Wiens,  Senior Vice President at Bank of America.  The panel discussion will be moderated by Daniel Bruckart, VP & Relationship Manager at Bank of America Merrill Lynch. The panel will address Obtaining Capital: Debt and Equity. The event will be held at the offices of KPMG, 4747 Executive Drive, San Diego CA 92121. (more…)

Objective Capital Partners Channing Hamlet to Address Mergers & Acquisitions in Today’s Economic Environment

San Diego, CA- January 16, 2017 – Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that Channing Hamlet, one of its Managing Directors, will be a guest panelist speaker at CONNECT’s Frameworks Workshop on February 2, 2017 from 8:00-11:30 AM. Mr. Hamlet will be joined by fellow panelists Clark Libenson, Corporate Partner at Allen Matkins, and Allen Walburn, Tax Partner at Allen Matkins. The panel will address the important topic of Mergers & Acquisition in Today’s Economic Environment. The event is sponsored by Allen Matkins and will be held at the offices of CONNECT, 4790 Eastgate Mall, San Diego, CA 92121. (more…)


Warning: extract() expects parameter 1 to be array, string given in /home/content/87/10888987/html/wp/wp-content/plugins/professional-linkedin-widget/professional-linkedin-widget.php on line 222